Adamis Pharmaceuticals Corp (ADMP)

[Seventeenseconds]

FDA decision due by the end of March for their Epinephrine (EPI) Pre-Filled Syringe (PFS) with revenues expected 1H 2015- - 10% market share is about $100 Million in sales. X 20% profit margin = $20 Million profit DIVIDED by 15 million shares outstanding = $1.33 EPS X conservative 30 PE = $40 PPS. ALSO - low risk, quicker path to revenues for a robust generic pipeline, including the APC-5000 generic Advair, that address markets totaling over $13 billion. Major Multi-Bagger here!